- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 59/42 - Composés non saturés contenant des groupes hydroxyle ou O-métal
Détention brevets de la classe C07C 59/42
Brevets de cette classe: 110
Historique des publications depuis 10 ans
|
4
|
4
|
9
|
8
|
7
|
6
|
4
|
1
|
5
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Brigham and Women's Hospital, Inc. | 2195 |
10 |
| University of Southern California | 2110 |
7 |
| Thetis Pharmaceuticals LLC | 23 |
7 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
5 |
| Universitat de les Illes Balears | 75 |
4 |
| DS Biopharma Limited | 31 |
4 |
| Noster Inc. | 68 |
4 |
| The Regents of the University of California | 19961 |
3 |
| Board of Regents, The University of Texas System | 5808 |
3 |
| New York Medical College | 44 |
3 |
| Pierre Fabre Dermo-Cosmetique | 368 |
3 |
| University Health Network | 1045 |
3 |
| Topsoe A/S | 898 |
3 |
| Dignity Sciences Limited | 15 |
2 |
| Ecover Co-ordination Center N.V. | 7 |
2 |
| Lipopharma Therapeutics, S.L. | 8 |
2 |
| Marrone Bio Innovations, Inc. | 105 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2855 |
2 |
| Shenzhen Dieckmann Tech Co., Ltd | 3 |
2 |
| Evonik Degussa GmbH | 1525 |
1 |
| Autres propriétaires | 38 |